Výsledky vyhľadávania
SYS 0118889 LBL 00000naa^^22^^^^^^^^450 005 20190802175536.5 100 $a 20151209a2015 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Clinical and biological significance of erlotinib therapy after pemetrexed in non-small cell lung cancer with wild-type EGFR $f N. Koyama, M. Suzuki 215 $c ilustr., obr., tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0118585 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 62, no. 6 (2015), s. 996-1004 $1 210 $a Bratislava $c AEPress $d 2015 $1 215 $a s. 841-1006 541 1-
$a Klinický a biologický význam terapie erlotinibom po liečbe pemetrexedom u nemalobunkového karcinómu pľúc s búrlivým typom EGFR $z slo 606 1-
$3 sllk_un_auth*d002289 $a karcinóm pľúc, nemalobunkový $x farmakoterapia $x patológia $x úmrtnosť $2 mesh 606 1-
$3 sllk_un_auth*d066246 $a receptory erbB $2 mesh 606 1-
$3 sllk_un_auth*d000971 $a protokoly kombinovanej protinádorovej chemoterapie $2 mesh 606 2-
$3 sllk_un_auth*d002945 $a cisplatina $2 mesh 606 2-
$3 sllk_un_auth*d018450 $a progresia choroby $2 mesh 606 2-
$3 sllk_un_auth*d016019 $a analýza prežívania $2 mesh 606 2-
$3 sllk_un_auth*d018572 $a prežívanie bez choroby $2 mesh 610 2-
$a erlotinib 610 2-
$a pemetrexed 700 -1
$3 sllk_un_auth*0037976 $a Koyama $b N. $4 070 701 -1
$3 sllk_un_auth*p0004219 $a Suzuki $b Mamoru $4 010 801 -0
$a SK $b BA006 $c 20151209 $g AACR2 SYS 0145842 LBL 00000naa^^22^^^^^^^^450 005 20180607103559.7 100 $a 20180502d2018 m y0sloy0103 ba 101 0-
$a eng $d eng 102 $a SK 200 1-
$a Effectiveness of nanoparticle albumin-bound paclitaxel plus carboplatin in non-small lung cancer patients with malignant pleural effusion $f N. Koyama ... [et al.] 215 $c ilustr. obr., sch., tab. 320 $a Bibliogr. odkazy 320 $a Res. angl. 463 -1
$1 001 sllk_un_cat*0145098 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 65, no. 1 (2018), s. 132-139 $1 210 $a Bratislava $c AEPress $d 2018 $1 215 $a s. 1-168 701 -1
$3 sllk_un_auth*0037976 $a Koyama $b N. $4 070 $p Department of Clinical Oncology, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan 801 -0
$a SK $b BA006 $c 20180502 $g AACR2